In a real-world setting, #CAR T-cell therapies including axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel demonstrate superior survival outcomes compared to traditional salvage therapy for patients with #FL. Learn more: https://t.co/ss4FFKDihr